
    
      This is a prospective, single-arm, observational, non-randomized clinical study that will
      enroll patients with heart failure who have had a CardioMEMS™ device implanted to monitor
      their diastolic pulmonary artery pressure. The study will recruit and enroll thirty
      participants. Participants will be monitored daily at home for a period of 30 days. Each day,
      the patient's diastolic pulmonary artery pressure will be measured by CardioMEMS™ and the
      ImpediMed's BIS technology. Participant's weight will also be taken each day.
    
  